INSM - Insmed Inc
7
$147.60
-$0.71 (-0.479%)
At market close
$144.66
-$2.94 (-1.991%)
After Hours 3/26/26, 8:46 PM
Score3.00/5
INSM
Valuation Score
View as %
Stock Unlock
1D
1W
1M
YTD
1Y
3Y
5Y
Max
Stock Profile
- Market Cap$31.82B
- IndustryBiotechnology
- EPS (TTM)-$5.97
- P/E (TTM)0.00
- Div & Yield--
- FCF Payout Ratio--
- P/S (TTM)52.46
- P/B43.05
- Diluted Shares213.80M
- Ex-Dividend--
- Next Earnings05-06
- Forward P/E0.00
- Payout Ratio--
- P/FCF (TTM)0.00
- FCF Yield--
- Earnings Yield-4.01%
- 52 Week Range
Score Card
Explore Scores Tab
3.00
Average
Valuation Model
Key Score
3.00
Average
Management
1.00
Very Bad
Growth
4.00
Good
Profitability
3.00
Average
Fin. Health
3.00
Average
Dividends
--
--
Analyst
4.00
Good
Insider Transactions
Explore Insider Tab
Buy
Sell
Market News
Page 1 of 21
Annual & Quarterly Financial Reports, Current Reports/Updates, Ownership & Insider Transactions, Proxy Statements, Other
Form 8-K
Current report pursuant to Section 13 or 15(d)
Filed on 2026-03-23 07:00:30
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-20 16:05:20
Form 144
Notice of proposed sale of securities pursuant to Rule 144
Filed on 2026-03-19 16:57:15
Form 144
Notice of proposed sale of securities pursuant to Rule 144
Filed on 2026-03-05 16:59:55
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-05 16:16:51
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-05 16:15:10
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-02-27 16:14:51
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-02-25 16:04:46
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-02-25 16:04:19
Form 144
Notice of proposed sale of securities pursuant to Rule 144
Filed on 2026-02-24 16:33:16
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-02-23 16:34:10
Form 144
Notice of proposed sale of securities pursuant to Rule 144
Filed on 2026-02-19 16:54:09
Page 1 of 21
Financials
Explore Financials Tab
Revenue
Earnings
Free Cash Flow
Price Targets
Go to Analyst Tab
High:
$253.05
71.4%
Avg:
$216.28
46.5%
Low:
$167.66
13.6%
Analyst Recommendations
Go to Analyst Tab
4.27
Very Good
35%
Strong Buy (9)
58%
Buy (15)
8%
Hold (2)
0%
Sell (0)
0%
Strong Sell (0)
About
- Website
- SEC Reports
- IPO Date1991-02-15
- IndustryBiotechnology
- Total Employees1,664
- ExchangeNasdaq Nms - Global Market
- Reporting CurrencyUSD
- GICSBiotechnology
- GICS SubBiotechnology
- GICS SectorHealth Care
- GICS GroupPharmaceuticals, Biotechnology & Life Sciences
Similar Stocks
Compare In Free Form
